Rebecca Haberman, MD
NYU Grossman School of Medicine
Scientist Development Award
COVID-19 in Patients with Inflammatory Arthritis is the swelling and tenderness of one or more joints. Learn more. : A Prospective Study on the Effects of Immunomodulatory Therapy on Susceptibility and Clinical Outcomes
Dr. Haberman is researching the impact of COVID-19 in patients with Any disorder in which loss of function or destruction of normal tissue arises from humoral or cellular immune responses to the body’s own tissue constituents.... diseases as well as the effectiveness of the COVID-19 vaccinations in the patient population.
“We hope that our project will empower patients to know more about their health in terms of COVID-19 and really encourage them to get vaccinated appropriately.”
To hear more from Dr. Haberman, watch the video above.
Donors like you make our important research funding possible. Consider donating today.